Use of bisphosphonates for hypercalcemia in a child with alveolar rhabdomyosarcoma

Turkish Journal of Pediatrics

Volumn 50, Issue 3, 2008, Pages 305-

  Çorapçioǧlu, Funda ^a   Mutlu, Hatice ^a   Deveci, Murat ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; PAMIDRONIC ACID;

CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CASE REPORT; FEMALE; HUMAN; HYPERCALCEMIA; LETTER; PARANEOPLASTIC SYNDROME; PATIENT REFERRAL; PRESCHOOL CHILD; REPEATED DRUG DOSE; RHABDOMYOSARCOMA; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

CHILD, PRESCHOOL; DIPHOSPHONATES; FEMALE; HUMANS; HYPERCALCEMIA; PARANEOPLASTIC SYNDROMES; RHABDOMYOSARCOMA, ALVEOLAR;

EID: 54749098451     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Andiran N, Alikaşifoǧlu A, Küpeli S, Yetgin S. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature. Turk J Pediatr 2006; 48: 248-252.
2. Young G, Shende A. Use of pamidronate in the management of acute cancer-related hypercalcemia in children. Med Ped Oncol 1998; 30: 117-121.
3. Mathur M, Sykes JA, Saxena VR, et al. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin. Pediatr Crit Care Med 2003; 4: 252-255.
4. de Camargo, B, Salateo R, Gutierrez y Lamelas R, et al. Unusual clinical evolution of a paratesticular alveolar rhabdomyosarcoma in a child. Med Pediatr Oncol 1990; 33: 422-424.
5. Kawasaki H, Takayama J, Nagasaki K, Yamaquchi K, Ohira M. Hypercalcemia in children with rhabdomyosarcoma. Pediatr Hematol Oncol 1998; 20: 327-329.